Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2007-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2006.10.013PMID 17197127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5‐fluorouracil

  2006cited by this paper
• Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.

  2006cited by this paper
• Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging.

  2006cited by this paper
• Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.

  2005cited by this paper
• Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC)

  2004cited by this paper
• A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer

  2004cited by this paper
• Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy.

  2004cited by this paper
• A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer

  2004cited by this paper
• Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

  2002cited by this paper
• Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.

  2002cited by this paper
• Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.

  2002cited by this paper
• Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.

  2002cited by this paper
• Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

  2001cited by this paper
• Clinical Pharmacokinetics of Capecitabine

  2001cited by this paper
• Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

  2001cited by this paper
• DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

  2001cited by this paper
• Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

  2001cited by this paper
• Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

  2000cited by this paper
• Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

  2000cited by this paper
• Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients

  1999cited by this paper
• Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.

  1998cited by this paper
• Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.

  1998cited by this paper
• Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

  1998cited by this paper
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

  1998cited by this paper
• Cancer of the colon, rectum and anus

  1998cited by this paper
• Improved survival with preoperative radiotherapy in resectable rectal cancer.

  1997cited by this paper
• The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma

  1995cited by this paper
• Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.

  1994cited by this paper
• Effective surgical adjuvant therapy for high-risk rectal carcinoma.

  1991cited by this paper
• Prolongation of the disease-free interval in surgically treated rectal carcinoma.

  1985cited by this paper
• PATTERNS OF RECURRENCE IN ADENOCARCINOMA OF THE RECTUM AND RECTOSIGMOID TREATED WITH SURGERY ALONE: IMPLICATIONS IN TREATMENT PLANNING WITH ADJUVANT RADIATION THERAPY

  1983cited by this paper
• Patterns of recurrence of rectal cancer after potentially curative surgery

  1983cited by this paper
• Patterns of Recurrence in Adenocarcinoma of the Rectum and Rectosigmoid Treated with Surgery Alone

  1982cited by this paper

• Radiation-Induced Fibrosarcoma in the Stoma: A Case Report and Literature Review

  2025cites this paper
• The efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

  2021cites this paper
• Gastrointestinal Cancers

  2019cites this paper
• Absolute Clinical Radiation Oncology Review

  2019cites this paper
• Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer

  2018cites this paper
• Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer

  2017cites this paper
• A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

  2016cites this paper
• Cytotoxic agents and radiation therapy: mechanisms of action and clinical applications

  2014influential citation
• Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.

  2013cites this paper
• Tailored rectal cancer treatment – a time for implementing contemporary prognostic factors?

  2013cites this paper
• Clinical benefits of concurrent capecitabine and cisplatin versus concurrent cisplatin and 5-flurouracil in locally advanced squamous cell head and neck cancer.

  2013influential citation
• Oncologic Outcome After Preoperative Chemoradiotherapy in Patients With Pathologic T0 (ypT0) Rectal Cancer

  2012cites this paper
• Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer

  2011cites this paper
• Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5‐fluorouracil and oral capecitabine

  2010cites this paper
• Pathologic Complete Remission after Preoperative Chemoradiation for Rectal Cancer: Analysis of Clinicopathologic Characteristics and Oncologic Outcome

  2008cites this paper
• Neoadjuvant Capecitabine Combined with Standard Radiotherapy in Patients with Locally Advanced Rectal Cancer

  2008cites this paper
• Integration of Novel Agents into Combined-Modality Treatment for Rectal Cancer Patients

  2007cites this paper
• Can the sequencing of concurrent capecitabine and radiation therapy improve the therapeutic ratio in rectal cancer?

  2007cites this paper
• Clinical Investigation : Gastrointestinal Cancer Simultaneous Integrated Boost e Intensity Modulated Radiation Therapy With Concomitant Capecitabine and Mitomycin C for Locally Advanced Anal Carcinoma : A Phase 1 Study

  year unknowncites this paper